IP Library Granted Patent US 10,556,887
Granted Patent B2
US 10,556,887 · App. 16/167,882 · Granted Feb 11, 2020

Processes for the preparation of Veliparib and intermediates thereof

Inventors: Prabhudas Bodhuri (Torrance, CA); Kaarina K. Milnes (Cambridge, CA); Melanie R. A. Green (Milton, CA); Gamini Weeratunga (Ancaster, CA); Boris Gorin (Oakville, CA)
Assignee: Apotex Inc.
C07D403/04C07D207/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,556,887
App. No.
16/167,882
Granted
Feb 11, 2020
Kind
B2
Abstract

The present invention provides processes for the preparation of Veliparib (1), as well as intermediates useful in the preparation thereof. In particular, processes are provided for the production of the compound of Formula (3), or a salt thereof, and cyclization to afford Veliparib (1).

Claims (51)

1. A process for preparing Veliparib (1):

or a salt thereof, comprising

(i) cyclizing, in the presence of an acid (A1), a compound of Formula (3):

wherein

G is CONH 2 or R;

R is CO 2 R 1 or CN; and

R 1 is selected from the group consisting of H, an aliphatic group, a substituted aliphatic group, aryl, substituted aryl, arylalkyl and substituted arylalkyl;

to provide either Veliparib (1) when G is CONH 2 , or,

when G is R, a compound of Formula (2):

 and

wherein

R is CO 2 R 1 or CN; and

R 1 is selected from the group consisting of H, an aliphatic group, a substituted aliphatic group, aryl, substituted aryl, arylalkyl and substituted arylalkyl; and

(ii) when G is R, converting the compound of Formula (2) to Veliparib (1).

2. The process of claim 1 , wherein G is CONH 2 .

3. The process of claim 1 , wherein G is R, R is CO 2 R 1 , and R 1 is H.

4. The process of claim 1 , wherein G is R, R is CO 2 R 1 , and R 1 is an aliphatic group.

5. The process of claim 4 , wherein R 1 is C1-C6 alkyl.

6. The process of claim 5 , wherein R 1 is methyl.

7. The process of claim 6 , wherein in step (ii), converting of the compound of Formula (2) to Veliparib (1) comprises treating the compound of Formula (2) with a source of ammonia.

8. The process of claim 7 , wherein the source of ammonia is selected from the group consisting of ammonia gas, ammonium hydroxide and a solution of ammonia in methanol solvent.

9. The process of claim 1 , wherein acid (A1) is a substantially anhydrous acid selected from the group consisting of carboxylic acids, sulfonic acids and mineral acids.

10. The process of claim 9 , wherein acid (A1) is acetic acid.

11. The process of claim 10 , wherein G in the compound of Formula (3) is CONH 2 , and Veliparib (1) is provided as a diacetic acid salt.

12. A process for the preparing a compound of Formula (3):

or a salt thereof, wherein

G is CONH 2 or R;

R is CO 2 R 1 or CN; and

R 1 is selected from the group consisting of H, an aliphatic group, a substituted aliphatic group, aryl, substituted aryl, arylalkyl and substituted arylalkyl;

comprising coupling, in the presence of a solvent (S2), of the compound of Formula (5):

with a compound of Formula (4):

or a salt thereof,

wherein

G is CONH 2 or R;

R is CO 2 R 1 or CN; and

R 1 is selected from the group consisting of H, an aliphatic group, a substituted aliphatic group, aryl, substituted aryl, arylalkyl and substituted arylalkyl.

13. The process of claim 12 , wherein G is CONH 2 .

14. The process of claim 13 , wherein solvent (S2) is selected from the group consisting of 1,4-dioxane, tetrahydrofuran, N,N-dimethylformamide and N-methyl-2-pyrrolidone.

15. The process of claim 13 , wherein the coupling is conducted at a temperature of at least about 50° C.

16. The process of claim 13 , wherein the coupling is conducted in the presence of a base (B2-B) that is selected from the group consisting of 4-(dimethylamino)pyridine and 1-methylimidazole.

17. A compound of Formula (3):

or a salt thereof, wherein

G is CONH 2 or R;

R is CO 2 R 1 or CN; and

R 1 is selected from the group consisting of H, an aliphatic group, a substituted aliphatic group, aryl, substituted aryl, arylalkyl and substituted arylalkyl.

18. The compound of claim 17 , or a salt thereof, wherein G is CONH 2 or CO 2 R 1 and R 1 is C1-C6 alkyl.

19. The compound of claim 17 , having the Formula (3-A):

or a salt thereof, or having the Formula (3-BA1):

or a salt thereof.

20. The compound of claim 17 , having the Formula (3-A):

or a salt thereof.

Assignments (2)
SECURITY INTEREST Recorded Apr 15, 2023
From: APOTEX INC.
To: THE BANK OF NOVA SCOTIA
Reel/Frame 063364/0710 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2019
From: BODHURI, PRABHUDAS; MILNES, KAARINA K.; GREEN, MELANIE R. A.; WEERATUNGA, GAMINI; GORIN, BORIS
To: APOTEX INC.
Reel/Frame 048012/0304 →
Continuity (2)
Provisional Application 62576125 · Oct 24, 2017
Related Publication 20190119257A1 · Apr 25, 2019